Interestingly, we also identified one EGFRvIII-positive breast lesion without EGFR amplification or somatic mutation in the MAPP cohort and another separate case of malignant phyllodes tumor with reported EGFRvIII and EGFR amplification on testing performed outside our institution. Here, EGFR is linked to malignant phyllodes tumor.